Arbutus Biopharma Corporation (ABUS)

NASDAQ: ABUS · IEX Real-Time Price · USD

2.50

-0.04 (-1.57%)

At close: Dec 29, 2023, 4:00 PM

2.48

-0.02 (-0.80%)

After-hours: Dec 29, 2023, 7:58 PM EST

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012 - 2008
Revenue	39.02	10.99	6.91	6.01	5.95	10.7	1.49	23.28	14.95	15.47	Upgrade
Revenue Growth (YoY)	255.11%	58.92%	15.02%	1.11%	-44.44%	617.64%	-93.59%	55.66%	-3.31%	9.64%	Upgrade
Gross Profit	39.02	10.99	6.91	6.01	5.95	10.7	1.49	23.28	14.95	15.47	Upgrade
Selling, General & Admin	17.83	17.14	14.85	17.73	16	16.13	39.44	26.44	8.68	5.55	Upgrade
Research & Development	84.41	65.5	49.34	57.6	57.93	62.68	61.25	51.51	38.71	21.46	Upgrade
Other Operating Expenses	0	0	0.06	74.76	21.79	42.83	392.44	49.25	0.99	0.61	Upgrade
Operating Expenses	102.24	82.64	64.25	150.09	95.73	121.63	493.13	127.2	48.39	27.62	Upgrade
Operating Income	-63.22	-71.65	-57.33	-144.07	-89.78	-110.93	-491.64	-103.92	-33.43	-12.15	Upgrade
Interest Expense / Income	1.73	2.86	4.01	2.11	0.23	0.26	0	0	0	0	Upgrade
Other Expense / Income	0.06	1.74	2.4	20.2	-28.66	-2.46	-2.47	-25.02	5.4	1.91	Upgrade
Pretax Income	-65.01	-76.25	-63.75	-166.38	-61.34	-108.73	-489.17	-78.9	-38.84	-14.06	Upgrade
Income Tax	4.44	0	0	-12.66	-4.28	-24.32	-105	-16.19	0	0	Upgrade
Net Income	-69.46	-76.25	-63.75	-153.72	-57.06	-84.41	-384.16	-62.72	-38.84	-14.06	Upgrade
Preferred Dividends	0	12.14	12.12	11.15	10.09	0.91	0	0	0	0	Upgrade
Net Income Common	-69.46	-88.39	-75.87	-164.87	-67.15	-85.32	-384.16	-62.72	-38.84	-14.06	Upgrade
Shares Outstanding (Basic)	151	106	76	57	55	55	53	45	22	15	Upgrade
Shares Outstanding (Diluted)	151	106	76	57	55	55	53	45	22	15	Upgrade
Shares Change	42.07%	40.10%	32.83%	3.24%	1.06%	3.11%	16.74%	110.44%	41.17%	6.86%	Upgrade
EPS (Basic)	-0.46	-0.83	-1.00	-2.89	-1.21	-1.56	-7.24	-1.38	-1.80	-0.92	Upgrade
EPS (Diluted)	-0.46	-0.83	-1.00	-2.89	-1.21	-1.56	-7.24	-1.38	-1.80	-0.92	Upgrade
Free Cash Flow	-35.87	-68.34	-51.67	-71.58	-68.98	-55.9	-61.86	-58.67	-13.4	-7.46	Upgrade
Free Cash Flow Per Share	-0.24	-0.64	-0.68	-1.25	-1.25	-1.02	-1.17	-1.29	-0.62	-0.49	Upgrade
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	Upgrade
Operating Margin	-162.03%	-652.07%	-829.23%	-2396.84%	-1510.18%	-1036.73%	-32973.78%	-446.46%	-223.59%	-78.58%	Upgrade
Profit Margin	-178.01%	-804.39%	-1097.31%	-2742.84%	-1129.54%	-797.42%	-25765.53%	-269.45%	-259.73%	-90.93%	Upgrade
Free Cash Flow Margin	-91.92%	-621.96%	-747.32%	-1190.88%	-1160.29%	-522.44%	-4148.63%	-252.06%	-89.59%	-48.25%	Upgrade
EBITDA	-61.86	-71.64	-57.76	-162.24	-58.94	-106.45	-488.07	-78.31	-38.31	-13.45	Upgrade
EBITDA Margin	-158.54%	-651.96%	-835.35%	-2699.10%	-991.34%	-994.81%	-32734.67%	-336.46%	-256.19%	-86.97%	Upgrade
Depreciation & Amortization	1.43	1.75	1.98	2.03	2.18	2.03	1.09	0.59	0.53	0.61	Upgrade
EBIT	-63.29	-73.39	-59.73	-164.27	-61.12	-108.47	-489.17	-78.9	-38.84	-14.06	Upgrade
EBIT Margin	-162.19%	-667.91%	-863.96%	-2732.84%	-1028.02%	-1013.76%	-32807.91%	-338.99%	-259.73%	-90.93%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).